federal_register: 2012-3319

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts regulation_id_numbers
2012-3319 Draft Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs; Availability Notice The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The draft guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs). 2012-02-14 2012 2 https://www.federalregister.gov/documents/2012/02/14/2012-3319/draft-guidance-on-investigational-new-drug-applications-for-positron-emission-tomography-drugs https://www.govinfo.gov/content/pkg/FR-2012-02-14/pdf/2012-3319.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is announcing the availability of a draft guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The draft guidance is intended to assist manufacturers of PET drugs...  

Links from other tables